Themis Medicare Ltd

Themis Medicare Ltd

Themis Medicare Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026, confirming the acceptance and listing of dematerialized securities.

Themis Medicare Ltd

Themis Medicare Ltd has announced a downgrade in its credit ratings by CARE Ratings Ltd due to a significant deterioration in profitability margins and debt coverage indicators. The ratings were downgraded from CARE BBB- to CARE BB+ for long-term bank facilities and from CARE A3 to CARE A4+ for short-term bank facilities. The company's profitability has been affected by increased competition and reduction in prices of its products. Despite this, the ratings continue to derive strength from the company's experienced promoters and management team, long track record of operations, and comfortable capital structure.

Themis Medicare Ltd

Themis Medicare Ltd has announced the results of its 56th Annual General Meeting (AGM), where all resolutions were passed with requisite majority. The company also declared a dividend for the financial year ended 31st March, 2026. The resolutions included the appointment of a new director and the ratification of remuneration of the cost auditor for the financial year 2026-27.

Themis Medicare Ltd

Themis Medicare Ltd has announced the results of its 56th Annual General Meeting (AGM), where all resolutions were passed with requisite majority. The company also declared a dividend for the financial year ended 31st March, 2026.

Themis Medicare Ltd

Themis Medicare Ltd has announced a downgrade in its credit rating by CARE Ratings Ltd from CARE BBB- to CARE BB+ for its long-term bank facilities and from CARE A3 to CARE A4+ for its short-term bank facilities.

Themis Medicare Ltd

Themis Medicare Ltd has announced a dividend of Re. 0.50 per equity share, aggregating to Rs. 4,60,50,060 for the Financial Year ended 31st March, 2026, and amendments to its Articles of Association.

Themis Medicare Ltd

Themis Medicare Ltd held its 56th Annual General Meeting on 30th September, 2026, where shareholders approved various resolutions, including the appointment of a director, dividend declaration, and amendment to the Articles of Association.

Themis Medicare Ltd

Themis Medicare Ltd held its 56th Annual General Meeting on September 30, 2026, where shareholders approved various resolutions, including the audited standalone and consolidated financial statements for the year ended March 31, 2026, and the appointment of a director. The company also declared a dividend for the financial year ended March 31, 2026.

Themis Medicare Ltd

Themis Medicare Ltd has withdrawn its proposed preferential issue of 45,95,795 convertible equity warrants, citing a need to consider fresh issues in the future to meet the company's working capital requirements.

Themis Medicare Ltd

Themis Medicare Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter and half year ending September 30, 2026.

Themis Medicare Ltd

Themis Medicare Ltd has announced its Annual Report for the Financial Year 2025-26, highlighting its resilience in a challenging operating environment. The company has focused on strengthening its core business fundamentals, with improvements in market positioning, product mix, and field force productivity. However, the API business faced headwinds due to pricing pressures in China and domestic players, leading to a decline in consolidated revenue to Rs. 342.24 crores.

Themis Medicare Ltd

Themis Medicare Ltd has released its Annual Report for FY 2025-26, highlighting a challenging operating environment, but resilience and commitment to innovation and operational excellence. The company's consolidated revenue stood at Rs. 342.24 crores, with EBITDA at Rs. 0.39 crores and PAT at Rs. 1.14 crores. Q4 FY26 witnessed a gradual recovery in profitability.

Themis Medicare Ltd

Themis Medicare Ltd has announced its 56th Annual General Meeting (AGM) to be held on 30th September 2026, along with the Annual Report for the financial year ended 31st March 2026. The company's revenue for FY26 stood at Rs. 342.24 crores, with EBITDA at Rs. 0.39 crores and PAT at Rs. 1.14 crores.

Themis Medicare Ltd

Themis Medicare Ltd has updated its company secretary/compliance officer's email ID and also updated the email ID of its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited.

Themis Medicare Ltd

Themis Medicare Ltd has published un-audited financial results for the quarter ended June 30, 2026, in the Indian Express and Financials Express newspapers. The results are also available on the company's website.

Themis Medicare Ltd

Themis Medicare Ltd has disclosed the authorized persons for determining materiality of events and making disclosures to stock exchanges under Regulation 30(5) of SEBI (LODR) 2015.

Themis Medicare Ltd

Themis Medicare Ltd has announced the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer, effective August 13, 2026, and the appointment of Mr. Suresh Savaliya as the new Company Secretary, Compliance Officer & KMP, also effective August 13, 2026.

Themis Medicare Ltd

Themis Medicare Ltd has announced the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP) of the Company, effective August 13, 2026. The Board of Directors also approved the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer, effective the same date. The company has also approved its Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Reports of the Statutory Auditors.

Themis Medicare Ltd

Themis Medicare Ltd has announced unaudited standalone and consolidated financial results for the quarter ended 30th June 2026, along with the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary and Compliance Officer, and the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer, and Key Managerial Personnel.

Themis Medicare Ltd

Themis Medicare Ltd held a board meeting on 13th August 2026, where they approved the un-audited standalone and consolidated financial results for the quarter ended 30th June 2026. The board also approved the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer and the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer & Key Managerial Personnel.